Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Vanguard Dividend Appreciation ETF

Abbott Labs

Colgate-Palmolive

CVS Health

Johnson & Johnson

Lowe's

Medtronic

Microsoft

NIKE

PepsiCo

QUALCOMM

Texas Instruments

Walmart

I hold 15 Dividend Achievers. That index is available in ETF form by way of Vanguard's Dividend Appreciation Fund - ticker VIG.

My Dividend Achievers Quarterly Review. More Than Up To The Investment Challenge Of COVID-19

Boot Barn Hlds

Michaels

March retail sales showed an industry in dire straits.

Why Shares of Walgreens, Michaels, and Boot Barn All Fell Wednesday

If you're not sure where to invest in the bear market, you'll want to take a second look at these two crazy-cheap stocks.

2 Pharmacy Stocks to Buy and Hold Amid the COVID-19 Crisis

Clorox

W.W. Grainger

JPMorgan Chase & Co

Kimberly-Clark

Procter & Gamble

Target

Each stock in this typically stable group was up 5% or more on Tuesday.

Why These 9 Dividend Aristocrats Are Surging Today

The new sites will use an Abbott Laboratories device that makes it possible for people to get test results in minutes.

CVS and Walgreens are opening more drive-thru coronavirus testing sites. Here's what to expect if you go

Walgreens announced on Tuesday that it will open 15 coronavirus testing sites across seven states beginning later this week.
The post Walgreens Coronavirus Testing Sites to Open in 7 States appeared first on InvestorPlace.

Walgreens Coronavirus Testing Sites to Open in 7 States

Arista Networks

Cisco Systems

Dell Technologies

Pfizer

Wells Fargo

Not all blue-chip stocks are good to hold forever. These companies are struggling to cut costs and could fall further.

7 Tarnished Blue-Chip Stocks to Ditch Now

Walgreens Boots Alliance will soon begin offering rapid coronavirus tests at 15 new sites across seven states.

Walgreens to Expand Drive-Thru COVID-19 Testing

The pharmacy chain says the new sites will use Abbott Laboratories' rapid testing technology and will be open to members of the public who are showing symptoms of COVID-19.

Walgreens to open 15 drive-thru testing sites for the coronavirus across 7 states

Walgreens will expand drive-thru testing for the Coronavirus strain COVID-19 to 3,000 tests a day at 15 new locations in seven states.

Walgreens Expands Coronavirus Testing To Seven States And 3,000 A Day

Comcast

Waste Management

These stocks are all trading near their 52-week lows.

3 Bargain Stocks You Can Buy Right Now: CMCSA, WBA & WM

Although the coronavirus (COVID-19) outbreak has introduced greater near-term risks for Walgreens Boots Alliance Inc (NASDAQ: WBA), the company’s same-store sales are likely to be fairly resilient once activity levels begin returning to normal, according to UBS.

UBS Upgrades Walgreens Boots Alliance, Says Valuation Reflects Heightened Near-Term Risks

Cia Brasileira de Distribuicao

Gap Inc

Nordstrom

Kohl's

Tapestry

Ulta Beauty

The retail environment is changing once again. These seven companies are having trouble adjusting.

7 Retail Stocks to Keep Your Distance From

Americans stocking up on their prescription drugs as COVID-19 stricken communities went on lockdown is hurting Walgreens - at least temporarily.

How Pandemic Hoarding Of Medicines Hurts Walgreens

 Luckin Coffee

Zoom Video

Simon Property Group

Facebook, Zoom Video, Walgreens, Simon Property Group and Luckin Coffee were our top stock trades for Friday.
The post 5 Top Stock Trades for Friday: FB, LK, WBA, ZM, SPG  appeared first on InvestorPlace.

5 Top Stock Trades for Friday: FB, LK, WBA, ZM, SPG 

Walgreens earnings have WBA stock down on Thursday despite the company beating both EPS and revenue expectations for the quarter.
The post Walgreens Earnings: WBA Stock Falls 8% Despite Q2 Beats appeared first on InvestorPlace.

Walgreens Earnings: WBA Stock Falls 8% Despite Q2 Beats

Walgreens Boots Alliance, Inc. (WBA) CEO Stefano Pessina on Q2 2020 Results - Earnings Call Transcript

Shares of Walgreens Boots Alliance Inc  fell 6% on Thursday after the drugstore retailer reported a steep decline in U.S.  same-store sales in the last week of March as customers stayed indoors due to the coronavirus outbreak.

Walgreens shares fall as coronavirus pandemic hits store sales

Rite Aid

All three retail pharmacy giants take a step back after Walgreens withdraws its full-year outlook.

Why Walgreens Boots Alliance, CVS Health, and Rite Aid Are Falling Today

The COVID-19 pandemic is making the pharmacy giant's near-term prospects uncertain.

Why Walgreen Boots Alliance's Q2 Earnings Beat Didn't Excite Investors

Walgreens Boots Alliance said its U. S. sales of health and wellness products jumped more than 30% in the first three weeks of March but stores are seeing “negative foot traffic” as the Coronavirus strain COVID-19 spreads around the world.

Walgreens Health Sales Jump But Store ‘Foot Traffic’ Down As Coronavirus Surges

Walgreens Boots Alliance Inc. (NASDAQ: WBA) released its fiscal second-quarter financial results before the markets opened on Thursday.

How Walgreens Earnings Are Holding Up Against COVID-19

Based on historical performance, Walgreens Boots Alliance (NASDAQ: WBA) appears to be an attractive bet compared to CVS Health (NYSE: CVS) in the current crisis.

Buy Walgreens Over CVS?

Walgreens has seen greater demand as the coronavirus pandemic causes customers to stock up on over-the-counter medications, prescriptions and items, such as cleaning supplies and disposable gloves.

Walgreens earnings top estimates, as the drugstore chain sees increased demand during coronavirus pandemic

Walgreens Boots Alliance Inc. WBA, -5.95% reported fiscal second quarter net income of $946 million, or $1.07 per share, down from $1.16 billion, or $1.24 per share, last year.

News for Walgreens Stock (WBA)